BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31793013)

  • 1. It takes two: uptake of carrier screening among male reproductive partners.
    Giles Choates M; Stevens BK; Wagner C; Murphy L; Singletary CN; Wittman AT
    Prenat Diagn; 2020 Feb; 40(3):311-316. PubMed ID: 31793013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The uptake of pan-ethnic expanded carrier screening is higher when offered during preconception or early prenatal genetic counseling.
    Larsen D; Ma J; Strassberg M; Ramakrishnan R; Van den Veyver IB
    Prenat Diagn; 2019 Mar; 39(4):319-323. PubMed ID: 30731021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Counseling for personal health implications identified during reproductive genetic carrier screening.
    Gbur S; Mauney L; Gray KJ; Wilkins-Haug L; Guseh S
    Prenat Diagn; 2021 Oct; 41(11):1460-1466. PubMed ID: 34426984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive male partner testing when the female is identified to be a genetic disease carrier.
    Simone L; Khan S; Ciarlariello M; Lin J; Trackman S; Heiman GA; Ashkinadze E
    Prenat Diagn; 2021 Jan; 41(1):21-27. PubMed ID: 32902862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded carrier screening: A current perspective.
    Mastantuoni E; Saccone G; Al-Kouatly HB; Paternoster M; D'Alessandro P; Arduino B; Carbone L; Esposito G; Raffone A; De Vivo V; Maruotti GM; Berghella V; Zullo F
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():41-54. PubMed ID: 30240948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of a cystic fibrosis carrier testing clinic for couples.
    Christie LM; Ingrey AJ; Turner GM; Proos AL; Watts GE
    Med J Aust; 2009 Nov; 191(9):499-501. PubMed ID: 19883345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interest in and uptake of genetic counseling for preconception carrier screening when offered to predominantly white reproductive-age persons seeking gynecologic care at a single U.S. academic medical center.
    Nesbit CB; Pollack CC; Mascia NS; LaCroix VH; Applebee DM; Bosco AW; Wilkinson-Ryan I; Erekson ED; Evans RH
    J Genet Couns; 2022 Feb; 31(1):109-119. PubMed ID: 34223670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal genetic carrier screening in the genomic age.
    Gregg AR; Edwards JG
    Semin Perinatol; 2018 Aug; 42(5):303-306. PubMed ID: 30241949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons for Declining Preconception Expanded Carrier Screening Using Genome Sequencing.
    Gilmore MJ; Schneider J; Davis JV; Kauffman TL; Leo MC; Bergen K; Reiss JA; Himes P; Morris E; Young C; McMullen C; Wilfond BS; Goddard KAB
    J Genet Couns; 2017 Oct; 26(5):971-979. PubMed ID: 28315134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes of the general population towards preconception expanded carrier screening for autosomal recessive disorders including inborn errors of metabolism.
    Nijmeijer SCM; Conijn T; Lakeman P; Henneman L; Wijburg FA; Haverman L
    Mol Genet Metab; 2019 Jan; 126(1):14-22. PubMed ID: 30563741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis carrier population screening in the primary care setting.
    Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
    Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the efficacy of three carrier screening workflows designed to identify at-risk carrier couples.
    Arjunan A; Torres R; Gardiner A; Kaseniit KE; Wootton J; Ben-Shachar R; Johansen Taber K
    Prenat Diagn; 2021 Jun; 41(7):896-904. PubMed ID: 33450092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal Carrier Screening for Spinal Muscular Atrophy.
    Wood SL; Brewer F; Ellison R; Biggio JR; Edwards RK
    Am J Perinatol; 2016 Oct; 33(12):1211-7. PubMed ID: 27611803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded carrier screening for recessively inherited disorders: economic burden and factors in decision-making when one individual in a couple is identified as a carrier.
    Shapiro AJ; Kroener L; Quinn MM
    J Assist Reprod Genet; 2021 Apr; 38(4):957-963. PubMed ID: 33501564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interest in expanded carrier screening among individuals and couples in the general population: systematic review of the literature.
    Van Steijvoort E; Chokoshvili D; W Cannon J; Peeters H; Peeraer K; Matthijs G; Borry P
    Hum Reprod Update; 2020 Apr; 26(3):335-355. PubMed ID: 32099997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Committee Opinion No. 691 Summary: Carrier Screening for Genetic Conditions.
    Obstet Gynecol; 2017 Mar; 129(3):597-599. PubMed ID: 28225421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded carrier screening in Chinese patients seeking the help of assisted reproductive technology.
    Xi Y; Chen G; Lei C; Wu J; Zhang S; Xiao M; Zhang W; Zhang Y; Sun X
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1340. PubMed ID: 32573981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missed opportunities: unidentified genetic risk factors in prenatal care.
    McClatchey T; Lay E; Strassberg M; Van den Veyver IB
    Prenat Diagn; 2018 Jan; 38(1):75-79. PubMed ID: 28384392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.